EFFECTOR Therapeutics (EFTR) Stock Highlights

0.28 | +0%

2024-06-26 05:33:07

eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs). Its product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The eIF4F complex is a central node where two of the most frequently mutated signaling pathways in cancer, the PI3K-AKT, and RAS-MEK pathways, converge to activate the translation of select mRNA into proteins that are frequent culprits in key disease-driving processes.

Statistics

Range Today

0.28 0.38

Volume Today 11.71M

Range 1 Year

0.25 17.75

Volume 1 Year 159.29M

Range 3 Year

0.25 40.42

Volume 3 Year 507.23M

Range 10 Year

0.25 40.42

Volume 10 Year 510.33M

Highlights

Market Capitalization 5.5M (micro)

Floating Shares 4.58M

Current Price 0.28

Price To Earnings -0.09

Price To Book 5.52

Earnings Per Share -12.57

Payout Ratio 0%

Performance

Latest 0%

1 Month -83.23%

3 Months -97.84%

6 Months -97.43%

1 Year -66.27%

3 Years -97.17%

5 Years -97.2%

10 Years -97.2%

Benchmarks

Market Capitalization

300 / 368

Gross Profits

171 / 278

Total Revenue

246 / 300

Total Rank

315 / 368

Free Cashflow

130 / 352

Performance 5 years

279 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.